Three numbers in the abstract
Where each one falls
Where it lands on the map
What it changes
Among 3 other studies
the abstract, start to end
… standard therapy (adjusted odds ratio, 0.67; 95% confidence interval [CI], 0.51 to 0.87; P=0.003); 6.5% with fenofibrate for intensive dyslipidemia therapy, versus 10.2% with placebo (adjusted odds ratio, 0.60; 95% CI, 0.42 to 0.87; P=0.006); and 10.4% with intensive blood-pressure therapy, versus 8.8% with standard therapy (adjusted odds ratio, 1.23; 95% CI, 0.84 to 1.79; P=0.29).
← favours treatmentfavours comparator →
could be chanceAdverse events & safety
OR 0.670.51–0.87
Adverse events & safety
OR 0.600.42–0.87
Adverse events & safety
OR 1.230.84–1.79
Other lipid agentsAdverse events & safety
Other lipid agents × adverse events & safetyharms?mixed
unlikelylikely
0.000.00 without it
← favours treatmentfavours comparator →
1 / 5